Trauma doctors may one day have a new weapon against drug overdoses: "nanocapsules" that sponge up the drugs and render them harmless.
University of Florida researchers will report at this week's American Chemical Society meeting that they used tiny oil-filled capsules to absorb a common antidepressant from rodent heart cells. People attempting suicide often use the antidepressant, amitriptyline, which causes heart attacks in overdose quantities.
"The heart cells' beating characteristics change when exposed to the drug," said Randy Duran, an associate professor of chemistry at UF and one of five researchers on the National Science Foundation-funded project. "Then they revert to back to normal as the cell is being cleansed with the nanocapsules."
The presentation is scheduled for Tuesday at the society's annual meeting in Anaheim, Calif.
Some 300,000 patients are treated for drug overdoses annually in the nation's trauma centers. While some drugs, such as heroin, can be treated with antidotes, others, including amitriptyline, offer doctors few options beyond standard treatments, such as flushing the drug from the body. An overdose of amitriptyline interferes with the heart's electrical impulse channels, causing arrhythmic abnormalities and, if taken in sufficient quantities, heart failure.
Seeking a new approach, researchers at UF and the Max Planck Institute for Polymer Research in Mainz, Germany, decided to try experimenting with tiny nanocapsules to sop up the drug.
"Nano" refers to almost unimaginably small molecule- or atomic-sized elements, with 1 nanometer equaling a billionth of a meter. For the project, the team developed capsules ranging from 150 to 600 nanometers, said Aleksa Jovanovic, a UF chemistry doctoral student and the lead researcher on the project. Each capsule consists of a polymer-coated silica shell surrounding a droplet of ethylbutyrate oil, a type of oil used in pharmaceutical products.
Magnet-like, amitriptyline molecules are attracted to oil, and they seek to bind with these capsules when the two are in close proximity, Jovanovic said.
The team placed rat heart cells on electrodes sensitive to the electric activity of the heart cells. The electrodes detect the activity and transmit the signal to a computer, conveying a unique real-time view of the heart cells' beating status, he said.
The team next dispensed a solution containing the nanocapsules on the cells. When the team added the amitriptyline, the cells continued to beat normally for a period of six minutes. Without the nanocapsules - that is with only the amitriptyline - the cell beats became both weaker and farther apart, Jovanovic said.
Bert Meijer, a professor of chemistry and chemical engineering at Eindhoven University of Technology in Eindhoven, The Netherlands, and an expert on polymer chemistry, said the team's experiments are novel and the results show promise.
"The way the nanocapsules are made is very elegant and shows the control that Professor Duran's group has in performing chemistry in self-assembled systems," he said. "Instead of using them as drug-delivery systems, the team very cleverly investigated their use as detoxification agents. I am very impressed by the results, and they open a new way of using nanosystems in biomedical applications."
Jovanovic emphasized the findings are preliminary and that many steps lie ahead before the nanocapsules could be used to treat overdoses.
For one thing, the six-minute window would need to be scrutinized. That time period may be long enough, because amitriptyline remains in the heart only for a short time before it circulates elsewhere in the body, but more study is needed, Jovanovic said.
Researchers also must determine what happens to the amitriptyline-filled capsules in the body. Jovanovic said he believed if they were small enough they would be excreted whole through the kidneys, but that must be tested. Also, he said, one of the chemicals on the surface of the oil core of the particles has proved toxic to the heart cells, necessitating a replacement ingredient.
Despite those unknowns, he said he is hopeful the capsules could eventually be used.
"I like this project a lot because I believe it will be applied one day," he said. "Other applications may also be possible, such as the purification of water."
University of Florida
Subscribe To SpaceDaily Express
Space Solutions For Health
Paris (ESA) Apr 28, 2004
ESA today announced the launch of its 'Space Solutions' initiative, a business-to-business provider of know-how and technologies to industries in the wellness market. The launch was announced at an event featuring an address by ESA astronaut André Kuipers, live from the International Space Station.
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2016 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.|